Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Current Developments in Biotechnology and Bioengineering: Human and Animal Health Applications provides extensive coverage of new developments, state-of-the-art technologies, and potential future trends, presenting data-based scientific knowledge and information on medical biotechnological interventions for human and animal health.
Drawing on the key development areas in this field, the book reviews biotechnological advances and applications in immunotechnology, vaccines and vaccinology, combinatorial libraries, gene and cell therapy, tissue engineering, and parasite and infectious disease diagnostics. This title outlines why biotechnological techniques in these areas are useful in a clinical context and considers their potential uses, limitations, and the ethical considerations surrounding their use.
- Provides development in human and animal health due to biotechnology
- Includes immunotechnology and vaccinology
- Outlines diagnostic techniques based on tissue and metabolic engineering principles
- Considers potential uses of the various biotechnology based techniques and the ethical issues raised in their use
Postgraduate, PhD students and researchers in academia, government and corporate research in the area of bioengineering/biochemical engineering, biomedical/biological engineering and industrial biotechnology
Section A: Immunotechnology
2. Monoclonal antibodies
4. Gene therapies
5. An 'omics approach towards CHO cell engineering.
Section B: Vaccines and Vaccinology
6. Progress in vaccinology
7. Viral recombinant vaccines
8. Bacterial recombinant vaccines
9. Rickettsial recombinant vaccines
10. Parasites recombinant vaccines
11. Vector-borne vaccines
12. Vaccines for the neglected diseases
13. Virus-like particles produced in plants as potential vaccines
14. Veterinary vaccines
15. New adjuvant in vaccinology
Section C: Combinatorial Libraries
17. Synthetic Peptide Libraries
18. Phage display: concept, innovations, applications and future.
Section D: Gene and Cell Therapy
19. Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications
20. Efficient Generation of Human iPSCs by a Synthetic Self-Replicative RNA
21. Expression of functional human hormones in a gene therapy model
22. Synthetic-biology on engineering bacteria to produce drugs
23. Non-Coding RNAs: Multi-Tasking Molecules in the Cell.
Section E: Tissue Engineering
24. Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized scaffold for tissue engineering.
25. Scale/topography of Substrates Surface Resembling Extracellular Matrix for Tissue Engineering
26. Regeneration and bioengineering of transplantable abdominal organs: current status and future challenges.
Section F: Infectious and Parasitic Diseases
27. Biotechnology applied to parasitizes diseases diagnosis: an overview
28. Biotechnology applied to infectious diseases diagnosis: an overview
29. Biopharmaceuticals and biosimilars.
- No. of pages:
- © Elsevier 2017
- 15th September 2016
- Hardcover ISBN:
- eBook ISBN:
Professor Thomaz - Soccol is Research Fellow of CNPq - Level 1A in the Federal University of Paraná, Brazil. She graduated in Veterinary Medicine from the Federal University of Paraná (1978), Master of Science (Biochemistry) from the Federal University of Paraná (1981) and Ph.D. in Parasitologie Faculte de Medecine - Universite Montpellier I - France (1993) and Post Doctorate in Parasitologie moleculaire the Institut de Recherche pour le Development, France, 1998. Professor Thomaz-Soccol is senior professor and heads the Centre for Molecular Biology from PhD program of Bioprocess Engineering and Biotechnology at Universidade Federal do Paraná. She has experience in the area of Parasitology and Biotechnology. She has supervised more than 100 masters and doctors, created the MSc and PhD in Microbiology, Parasitology and Pathology at the UFPR, Curitiba and Industrial Biotechnology at the Positive University, Curitiba. Her main focus is the area of the development of biotechnological inputs for human and veterinary immunodiagnostic and vaccine compositions, and related to infectious parasitic diseases. She has 492 publications/communications, which include 10 patents and design copyrights, 04 books, 31 book chapters, and 240 original and review papers, with h index of 28 and > 5422 citation (Google Scholar).
Research Fellow of the National Council for Scientific and Technological Development, Federal University of Parana, Brazil
Professor Ashok Pandey is currently Distinguished Scientist at the Centre for Innovation and Translational Research, CSIR-Indian Institute of Toxicology Research, Lucknow, India and Executive Director (Honorary) at the Centre for Energy and Environmental Sustainability – India. Formerly, he was Eminent Scientist at the Center of Innovative and Applied Bioprocessing, Mohali and Chief Scientist & Head of Biotechnology Division and Centre for Biofuels at CSIR’s National Institute for Interdisciplinary Science and Technology, Trivandrum. His major research and technological development interests are industrial & environmental biotechnology and energy biosciences, focusing on biomass to biofuels & chemicals, waste to wealth & energy, industrial enzymes, etc. Professor Pandey is Adjunct/Visiting Professor/Scientist in universities in France, Brazil, Canada, China, Korea, South Africa, and Switzerland and also in several universities several in India. He has ~ 1375 publications/communications, which include 16 patents, 83 books, ~ 700 papers and book chapters, etc with h index of 97 and >43,000 citations (Goggle scholar). He has transferred several technologies to industries and has done industrial consultancy for about a dozen projects for Indian/international industries. Professor Pandey is the recipient of many national and international awards and honours, which include Highest Cited Researcher (Top 1% in the world; Top 10 among in India), Clarivate Analytics, Web of Science (2019); Yonsei Outstanding Scholar, Yonsei University, Seoul, Korea (2019), Highest Cited Researcher (Top 1% in the world; Top 10 among in India), Clarivate Analytics, Web of Science (2018); Life-Time Achievement Award from the Biotech Research Society, India (2018); Life-Time Achievement Award from Venus International Research Awards (2018), Most Outstanding Researcher Award from Career360 (2018), Life-Time Achievement Award from the International Society for Energy, Environment and Sustainability (2017); Academician of European Academy of Sciences and Arts, Austria (2015); Honorary Doctorate degree from Univesite Blaise Pascal, France (2007); Thomson Scientific India Citation Laureate Award, USA (2006); UNESCO Professor (2000); Raman Research Fellowship Award, CSIR (1995); GBF, Germany and CNRS, France Fellowships (1992) and Young Scientist Award (1989), etc. He is Fellow of various academies, which include Royal Society of Biology, UK (2016); International Society for Energy, Environment and Sustainability (2016); National Academy of Sciences, India (2012); Association of Microbiologists of India (2008), International Organization of Biotechnology and Bioengineering (2007) and the Biotech Research Society, India (2005). Professor Pandey is Founder President of the Biotech Research Society, India (www.brsi.in); Founder & International Coordinator of International Forum on Industrial Bioprocesses, France (www.ifibiop.org), Chairman of the International Society for Energy, Environment & Sustainability (www.isees.in), Editor-in-chief of Bioresource Technology (http://ees.elsevier.com/bite/), Honorary Executive Advisor of Journal of Water Sustainability (http://www.jwsponline.com/) and Journal of Energy and Environmental Sustainability (www.jees.in), Subject Editor of Proceedings of National Academy of Sciences, India (https://www.springer.com/life+sciences/journal/40011) and editorial board member of several international and Indian journals
Distinguished Scientist, Centre for Innovation and Translational Research, CSIR-Indian Institute of Toxicology Research, Lucknow, India
Prof Rodrigo R Resende graduated in Pharmacy, Biochemistry (2002) and Biological Sciences (2003) from the Federal University of Alfenas, Ph.D. (Biochemistry) from the University of São Paulo (2007) and Post-Doctorate in Biophysics (2008) and in Physics of Nanomaterials (2009). Head of the Cell Signaling and Nanobiotechnology Laboratory, Adjunct Professor Department of Biochemistry and Immunology, Federal University of Minas Gerais. Founding President of Brazilian Society for Cell Signaling and Founding President of Nanocell Institute, a non-profit organization for researches development, sciences and education promotion in Brazil (www.institutonanocell.org.br), also he was the founder and creator of the popular science journal Nanocell News (www.nanocellnews.com.br). He created the MSc in Biotechnology at UFSJ, Minas Gerais. His research expertise is in the areas of biochemical technology, nanobiotechnology, cell signaling, stem cells differentiation, direct reprogramming somatic cells and tissue engineering. He has published over than 75 papers, six books, 23 book chapters and has nine patents. He has supervised 14 master, doctors and pos-doctors.
Adjunct Professor and Head of the Cell Signaling and Nanobiotechnology Laboratory, Department of Biochemistry and Immunology, Federal University of Minas Gerais, Brazil
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.